Currently, there are 152.32M common shares owned by the public and among those 30.30M shares have been available to trade.
The company’s stock has a 5-day price change of 10.50% and 11.09% over the past three months. ACT shares are trading 8.89% year to date (YTD), with the 12-month market performance up to 19.16% higher. It has a 12-month low price of $28.98 and touched a high of $37.42 over the same period. ACT has an average intraday trading volume of 317.72K shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 2.69%, 3.97%, and 3.52% respectively.
Institutional ownership of Enact Holdings Inc (NASDAQ: ACT) shares accounts for 18.98% of the company’s 152.32M shares outstanding.
It has a market capitalization of $5.34B and a beta (3y monthly) value of 0.59. The stock’s trailing 12-month PE ratio is 8.07, while the earnings-per-share (ttm) stands at $4.37. The company has a PEG of 4.44 and the debt-to-equity ratio at 0.15. Price movements for the stock have been influenced by the stock’s volatility, which stands at 4.32% over the week and 2.97% over the month.
Earnings per share for the fiscal year are expected to decrease by -5.41%, and 2.88% over the next financial year. EPS should shrink at an annualized rate of 1.82% over the next five years, compared to 4.81% over the past 5-year period.
Looking at the support for the ACT, a number of firms have released research notes about the stock. UBS stated their Neutral rating for the stock in a research note on December 06, 2023, with the firm’s price target at $29. BofA Securities coverage for the Enact Holdings Inc (ACT) stock in a research note released on November 13, 2023 offered a Buy rating with a price target of $30. BofA Securities was of a view on May 09, 2023 that the stock is Neutral, while Keefe Bruyette gave the stock Outperform rating on February 08, 2023, issuing a price target of $25- $26.50. Credit Suisse on their part issued Underperform rating on January 09, 2023.
